Medicure Inc's stock experienced a notable jump, reflecting investor confidence amid its recent financial disclosures.
In yesterday's trading session, Medicure Inc (MPH.V) saw its stock price surge by 15.41%, closing at CA$4.27. This uptick comes after the company announced its recent financial results and ongoing developments in its business strategy.
Advertisement
Medicure Inc
MPH.V
MPH.V
Medicure Inc
WealthAwesomeMarket cap
$44.56M
52W high
$4.95
52W low
$0.85
1W change
+37.92%
Beta
1.15
Analyst Price Targets
Based on analyst covering MPH · as of Sep 17, 2026
Wall Street analysts forecast MPH stock price to fall 31.9% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.80
-31.9% Upside
Current Price
C$4.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MPH's historical volatility
30-Day Vol
128.8%
Annualized
90-Day Vol
137.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$4.91
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.36 | C$2.80 – C$6.80 |
| 60 trading days | C$4.63 | C$2.47 – C$8.68 |
| 90 trading days | C$4.91 | C$2.28 – C$10.61 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The significant rise in Medicure's stock price may indicate positive sentiment among investors, particularly in light of its recent financial performance and strategic initiatives.
15.41% Surge in Stock Price
Medicure Inc's stock price jumped significantly, reflecting a strong market reaction to its recent financial disclosures.
Bull case
Investors might feel optimistic about Medicure's reported net revenue of CA$7.9 million for Q1 2026, which suggests potential growth in its operations. The scheduled conference call on May 25 could offer more insights into the company's future plans and performance.
Bear case
Despite the positive stock movement, Medicure's net loss of CA$406,000 raises concerns about its profitability and long-term financial health. Investors should keep an eye on the company's ability to turn revenue into profit moving forward.
Advertisement
Recent Financial Performance
Medicure Inc recently reported its financial results for Q1 2026, showcasing a net revenue of CA$7.9 million. While the company did experience a net loss of CA$406,000, the revenue figure indicates potential growth, which likely fueled investor interest and contributed to the stock's surge.
Market Reaction and Future Outlook
The 15.41% increase in Medicure's stock price reflects a strong market reaction, suggesting that investors are optimistic about the company's future. The upcoming conference call on May 25, where management will discuss the financial results and future strategies, could further influence investor sentiment and stock performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
